EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The antimicrobial peptide Cec4 has therapeutic potential against clinical carbapenem-resistant Klebsiella pneumoniae

Lu Li iD, Yang Zeng, Minfang Tian, Huijun Cao, Zhilang Qiu, Guo Guo, Feng Shen iD, Yuping Wang iD, Jian Peng iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.02738-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Lu Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit/Centre for Clinical Laboratories, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, People's Rep…. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Anti-Bacterial Agents, Antimicrobial Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation for Young Scientists of Shanxi Province, Science and Technology Program of Guizhou Province, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid increase in carbapenem-resistant Klebsiella pneumoniae (CRKP) infections, along with the cross-resistance of CRKP to other antibiotics, has created an urgent need for novel therapeutic agents. Among the potential options for next-generation antibiotics, antimicrobial peptides (AMPs) show great promise. In this study, we aimed to elucidate the mechanisms underlying the antibacterial activity against CRKP of an antibacterial peptide named Cecropin-4 (Cec4), which we successfully identified previously. Our results demonstrate that Cec4 not only exhibits rapid antibacterial activity but also effectively inhibits and eradicates bacterial biofilm at a low concentration of 8 µg/mL. Additionally, when used in combination with traditional antibiotics, Cec4 enhances their antibacterial effect. Microscopy techniques, including transmission electron microscopy (TEM), confocal laser scanning microscopy, and scanning electron microscopy (SEM), found that Cec4 destroyed bacteria’s cell membrane integrity and increased the membrane permeability (flow cytometry instrument technology further characterization of Cec4 against K. pneumoniae bacteria antibacterial effect). Furthermore, in vitro experiments demonstrated that Cec4 binds to bacterial DNA and RNA of CRKP. Moreover, in vivo studies using a mouse skin wound model confirmed the efficacy of Cec4, and transcriptomic analysis shed light on the molecular mechanisms underlying its antibacterial activity. Based on our findings, Cec4 appears to be a promising candidate for combating CRKP infections. IMPORTANCE The rapid increase in carbapenem-resistant Klebsiella pneumoniae (CRKP) infections and the serious cross-resistance to multiple antibiotics make the development of new therapeutic drugs urgent. Antimicrobial peptides (AMPs) have attracted much attention as a potential option for the next generation of antibiotics. Previous studies have identified the antimicrobial peptide Cecropin-4 (Cec4), and this study further explored its antimicrobial mechanism against CRKP. Studies have found that Cec4 shows high antibacterial activity at low concentrations, can inhibit and eradicate bacterial biofilms, and can also enhance the efficacy of traditional antibiotics. Its mechanism of action, such as destroying cell membranes and binding nucleic acid, has been revealed by various techniques, and its effectiveness has been confirmed in vivo , providing a promising candidate drug for combating CRKP infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeKlebsiella InfectionsAnti-Bacterial AgentsAntimicrobial PeptidesCarbapenemsCarbapenem-Resistant EnterobacteriaceaeAntimicrobial Cationic PeptidesAnimalsBiofilmsMiceMicrobial Sensitivity TestsHumans

Stichwörter der Autor:innen

CRKPKlebsiella pneumoniaeantibacterial activityantibacterial mechanismantimicrobial peptide

Substanzen

Anti-Bacterial AgentsAntimicrobial PeptidesCarbapenemsAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • Department of Intensive Care Unit/Centre for Clinical Laboratories, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, People's Republic of China.
  • Key Laboratory of Infectious Immune and Antibody Engineering of Guizhou Province, Cellular Immunotherapy Engineering Research Center of Guizhou Province, School of Biology and Engineering/School of Basic Medical Science…
  • Guizhou Institute of Precision Medicine, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, People's Republic of China.
  • The Engineering Research Center of Health Medicine Biotechnology of Institution of Higher Education of Guizhou Province, Guiyang, Guizhou, People's Republic of China.

ORCID-Profile: Lu Li, Feng Shen, Yuping Wang, Jian Peng

Förderung

  • Natural Science Foundation for Young Scientists of Shanxi Province
  • Science and Technology Program of Guizhou Province
  • China Postdoctoral Science Foundation
  • Guizhou Medical University
  • Department of Health of Guizhou Province

Zitieren

APA

Li, L., Zeng, Y., Tian, M., Cao, H., Qiu, Z., Guo, G., Shen, F., Wang, Y., & Peng, J. (2025). The antimicrobial peptide Cec4 has therapeutic potential against clinical carbapenem-resistant Klebsiella pneumoniae. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02738-24

Vancouver

Li L, Zeng Y, Tian M, Cao H, Qiu Z, Guo G, et al. The antimicrobial peptide Cec4 has therapeutic potential against clinical carbapenem-resistant Klebsiella pneumoniae. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02738-24

BibTeX
@article{Li2025,
  author = {Li, Lu and Zeng, Yang and Tian, Minfang and Cao, Huijun and Qiu, Zhilang and Guo, Guo and Shen, Feng and Wang, Yuping and Peng, Jian},
  title = {The antimicrobial peptide Cec4 has therapeutic potential against clinical carbapenem-resistant Klebsiella pneumoniae},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.02738-24}
}
Kostenlos starten →